Background Monitoring iodine status during pregnancy is essential to prevent iodine-related disorders. The objectives of this study are to estimate iodine intake and excretion, to assess their association and to evaluate the compliance of the recommendations in a multicentre cohort of pregnant women. Methods Cross-sectional data on maternal iodine nutritional status, compiled between weeks 8 and 22 of gestation in three Spanish areas (Valencia, Gipuzkoa and Sabadell), were analysed. Information on iodine intake from diet, salt and supplements was estimated through questionnaires. Spot urine samples were analysed for urinary iodine concentration (UIC). Tobit regression analysis was used to assess the association between iodine intake and UIC. Results 1522 women were included in the study.
iodine supplements, 93.3% in Gipuzkoa and 11.0% in Sabadell. Prevalence of iodised salt consumption was 50.5% in the whole sample. UIC was associated with intake of supplements, iodised salt, dietary iodine and water. UIC levels were lower than expected according to the estimated iodine intake. Conclusion Median UIC reflected iodine deficiency according to WHO reference levels, except in Gipuzkoa where supplements are widely consumed. It is necessary to strengthen iodised salt consumption since it is already far from the objective proposed of coverage of 90% of households. More data would be valuable to assess the correspondence between iodine intake and excretion during pregnancy.
Iodine is an essential micronutrient required for the synthesis of thyroid hormones, which regulate many enzymatic and metabolic processes in the organism. The requirements of thyroid hormones are increased during pregnancy, mainly during the first half of gestation, when the fetus is completely dependent on maternal transference of thyroid hormones for optimal brain development. 1 An increment of about 50% of thyroid hormone production is required to face the metabolic changes associated with pregnancydthat is, incremented requirements from the mother, transference to the fetus and a supposed increase in the renal clearance of iodine. 2 3 Monitoring iodine status in the population is essential to prevent iodine deficiency disorders (IDD), especially in vulnerable groups like pregnant and lactating women and young children. 4e6 However, there is also an increasing concern about the importance of monitoring the risk of thyroid disease due to an excessive consumption of iodine, which has been associated with iodine-induced hyperthyroidism 7 and a higher prevalence of subclinical and even overt hypothyroidism. 8 9 Spain was considered an iodine-deficient country until 1993. 10 More recently, Spain was classified as an iodine-sufficient country, although in a borderline situation, and underlining the absence of national representative data. 6 Recent Spanish studies in pregnant women have shown iodine deficiency in some areas, according to the new WHO recommendations. 11e15 Nevertheless, uncertainty still remains in most regions of Spain, mainly due to lack of a nationwide monitoring system and the great variability observed among regions in iodised salt coverage and implementation of supplementation programmes. 6 Recent results from our study group have shown that consumption of iodine supplements at a dose of $200 mg/day may be related to an increased risk of elevated thyroid-stimulating hormone, suggesting that the extra dose of iodine added by supplements might result in an iodine excess affecting thyroid function. 16 These findings raised the need of assessing the iodine nutritional status of pregnant women from the study areas and to ascertain whether they had an adequate iodine intake according to current recommendations.
WHO and the Food and Agriculture Organization of the United Nations 17 have established reference levels on iodine intake during pregnancy to cope with its increased requirements. The recommended nutrient intake by WHO/Food and Agriculture Organization, which is the amount that meets the needs of almost all healthy individuals in a group, has recently been increased from 200 to 250 mg/day.
On the other hand, a total daily intake greater than 500 mg/day is not recommended as it theoretically may be associated with impaired thyroid function. 18 The recommended nutrient intake is intended to be used as a goal for the daily intake of iodine by individuals, but it is not recommended when comparing groups. 19 20 To study adequacy for group estimates of nutrient intake, the use of the estimated average requirement (EAR) as a cut-off point has been proposed, which is the daily iodine intake that meets the requirement of half of the healthy individuals in a particular life stage.
Surveillance through estimate of dietary iodine intake may, however, be a difficult task due to the lack of cost-efficient and valid instruments, and because iodine from diet and from iodised salt and supplement use must be taken into account. This has led to the establishment of median urinary iodine concentration (UIC) as the main impact indicator of iodine status in populations. 22 In the general population, a median UIC ranging from 100 to 199 mg/l is considered to indicate an adequate iodine intake. 22 Since the requirement for iodine is increased during pregnancy, new WHO/Unicef recommendations state a median UIC from 150 to 250 mg/l as an adequate iodine intake during pregnancy. 22 In this article, we describe the variability in the iodine nutritional status, as measured by UIC levels and by iodine intake estimates from diet, iodised salt and supplements, among population-based samples of pregnant women from three Spanish areas with different supplementation practices. We also evaluate the level of compliance of the current WHO and Institute of Medicine recommendations for pregnant women, applied over UIC and over iodine intake. Finally, we assessed the association of iodine intake estimates with UIC during pregnancy.
METHODS Population
The INMAdINfancia y Medio Ambiente (Environment and Childhood)dproject is a multicentre prospective mother and child cohort study that aims to evaluate the impact of exposures to most prevalent environmental pollutants, and the role of diet on foetal and infant growth, health and development. 23 We analysed cross-sectional data on maternal iodine nutritional status from three cohortsdValencia, Gipuzkoa (Basque . For this study, we included only women with complete information on iodine intake from diet and supplements, with measured UIC between weeks 8 and 22 of gestation, and without previously diagnosed thyroid pathology (total subsample: 1522; 655 from Valencia, 585 from Gipuzkoa and 282 from Sabadell). The study was approved by the ethical committees of the centres involved in the study. All women participating in the study signed informed consent.
Study variables
General characteristics and obstetric history of pregnant women were obtained through questionnaires administered by personal interview.
Usual dietary intake was assessed using a 100-item, semiquantitative food-frequency questionnaire (FFQ). The FFQ was an adapted version of the Willett questionnaire, 24 and had been previously used and validated using four 1-week diet records among adults in Valencia. 25 Pregnant women were asked how often, on average, they had consumed each type of item since their last menstrual period until the time of the interview. Iodine content of the food items was primarily obtained from food composition tables from the US Department of Agriculture 26 and adapted according to food composition information from the UK 27 and Spain. 28 In those women who reported the use of iodised salt, its added iodine content was taken into account in the specific FFQ item on "pinches of salt" usually added at the table to raw and cooked foods. A pinch of salt was estimated as 0.4 g. Since table salt is iodised in Spain at 60 mg of iodine per kilogram, 0.4 g of salt would be equivalent to 24 mg of iodine per pinch of salt. Furthermore, the same amount (24 mg of iodine) was assumed to be added per portion of a predetermined list of 20 cooked food items, according to usual food cooking practices. Daily iodine intake from foods and foods plus salt was adjusted for total energy intake by the residual method. 29 Information on brand name, dose and timing of consumption of specific potassium iodide supplements and/or vitamin/mineral preparations containing iodine was obtained by a structured questionnaire. Total iodine intake was categorised according to the estimated average requirement (EAR¼160 mg/day) and the threshold not recommended by WHO to be exceeded (500 mg/day) as follows: inadequate or insufficient intake (<EAR¼160 mg/day), adequate intake (160e500 mg/day) and excessive intake (>500 mg/day).
Given the expected opposite relationship between UIC and total urine excretion, daily water intake estimate from foods and beverages was also accounted for in the analyses. 30 31 Fasting spot urine samples were obtained in Valencia, while in Sabadell and Gipuzkoa urine samples were mostly non-fasting. Samples were stored at À208C until delivery to the reference laboratory (Normative Public Health Laboratory of Bilbao, Basque Country). Laboratory analytic methods and quality control procedures are described elsewhere. 32 Briefly, iodine concentrations were measured in a spot urine sample by a paired-ion reversed-phase high-performance liquid chromatography with electrochemical detection and a silver working electrode.
Median UIC was compared with the current WHO recommended range (150e249 mg/l). 22 This recommendation has based its lower value (150 mg/l) on the recommended nutrient intake of 250 mg/day. Assuming that 90% of iodine intake is excreted in the urine during pregnancy, and that the average volume of urine is 1.5 l/day, of the 250 mg/day of iodine ingested, 225 mg would be excreted in urine at a concentration of 150 mg/l.
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Statistical analysis
Descriptive statistics of maternal characteristics and iodinerelated variablesdiodine intake from diet, iodised salt and supplements, and UICdwere performed for the three areas. c 2 , ANOVA, equality-of-medians and KruskaleWallis tests were used to contrast study variables by area.
Finally, we performed a multivariate model to evaluate the degree of association between UIC and iodine intake variables. UIC distribution was right skewed, so levels were transformed using natural logarithm. Due to the presence of quantification limits in the determination of UIC, tobit regression for censored data was used because it provides maximum likelihood estimations of the coefficients in presence of quantification limits in the dependent variable. 33 Iodine intake variables were forced into the model; other variables were included if the likelihood ratio test had a level of significance at p<0.1. We included interaction terms between study variables and area to contrast if a common regression coefficient could summarise the relationships. No significant interactions were found (likelihood ratio test with p>0.05 in all cases), so both stratified and joint analyses are shown. Statistical analysis was carried out using Stata statistical package version 9.0 (Stata Corp).
RESULTS
Several characteristics of pregnant women were significantly different by geographic area. Pregnant women from Valencia were younger (mean age 30.2 vs 31.6 years in Gipuzkoa and 31.1 years in Sabadell). Median gestational age at urinary iodine sampling was 12.4 weeks in Valencia, 13.6 weeks in Gipuzkoa and 13.3 weeks in Sabadell. Women in Gipuzkoa also showed a higher educational level and a lower proportion of immigrants than women in the other areas (table 1) . Table 2 shows the distribution of urinary iodine concentration (UIC) and iodine intake variables in women from the three areas.
The highest UIC was found in Gipuzkoa (median 168 mg/l) and the lowest (median 94 mg/l) in Sabadell. Of the pregnant women from the whole sample, 50.5% consumed iodised salt. Consumption of iodine supplements was observed in 49% of women from Valencia, 93% in Gipuzkoa and 11% in Sabadell. No differences were found in iodine intake from diet among areas (median intake 145 mg/day). Merging iodised salt and supplement consumption in iodine intake estimates led to great differences among areas: median total intake of iodine was 285 mg/day in Valencia, 385 mg/day in Gipuzkoa and 169 mg/day in Sabadell.
The level of compliance with recent WHO recommendations about the distribution of UIC 22 was then evaluated (figure 1).
Median UIC (all cohorts) was within the new recommended range (150e250 mg/l) for pregnant women if, and only if, they took pharmacological supplements. Moreover, median UIC in women who did not take iodised salt nor supplements fell below 100 mg/l.
If women were classified by their sources of iodine consumption, 59.0% of those whose only means of iodine intake was diet had an inadequate intake (<160 mg/day), according to the EAR. For women taking iodised salt, this percentage was reduced to 4.1%, and it was about zero when women took pharmacological supplements containing at least 100 mg of elemental iodine (table 3) . On the other hand, 18.3% of women taking iodised salt and supplements had a total iodine intake higher than 500 mg/day, the amount recommended by WHO not to be exceeded. 18 Moreover, a daily consumption of supplements containing $300 mg of iodine, combined with iodised salt, was related to a median UIC above the requirements (>250 mg/l).
Applying the theoretical ingestion/excretion factor referred to in Methods 18 to median UIC, the estimated median iodine intake yp Value from the equality-of-medians test (UIC), c in the whole sample would have been 228.3 mg/day (¼137 mg/ l31.5 l/day31/0.9 ingested/excreted), a lower value than that estimated by the FFQ plus supplementation (316 mg/day). Table 4 shows the variables associated with UIC in the stratified and the joint multivariate analyses. Iodine intake from diet, iodised salt consumption and supplementary iodine intake were all independently associated with UIC in the joint model. Levels in Sabadell were 18.2% lower than in Valencia, not explained by the lower prevalence of iodised salt and supplement intake.
DISCUSSION
This study illustrates the iodine status of pregnant women from three geographical areas of Catalonia, Basque Country and Valencia in Spain, with different patterns concerning iodised salt consumption and different implementation of supplementation programmes. Prevalence of iodised salt consumption was 50.5% in the whole sample. In Gipuzkoa, almost all women consumed specific potassium iodide supplement as a part of an IDD prevention programme, and this was the only area that achieves WHO recommendations for UIC levels. Diet and iodised salt use did not increase UIC enough to achieve the recommended range of 150e249 mg/l, and only women using iodine supplements reached the median UIC as recommended by WHO. However, pregnant women using iodised salt reached the recommended levels for general population (100e200 mg/l). The prevalence of inadequate iodine intake was low (<5%) in iodised salt consumers; however, they had a higher risk of excessive intake (>500 mg/day) when supplements were added (18%).
The UIC levels were lower than expected according to the estimated iodine intake. This pattern was also observed in a Danish monitoring programme, 34 noting that iodine from dietary supplements might not be completely absorbed. Some other alternative explanations can be suggested: levels of iodine intake from iodised salt could be overestimated by the FFQ; alternatively, lower levels in UIC could be motivated by use of morning samples that have been associated with lower UIC, 35 or by a sub-estimation of 24 h urine volume. 31 UIC in Valencia and Gipuzkoa was higher than levels found in recent Spanish studies of pregnant women. 11e15 The Sabadell cohort, however, shares the situation of deficiency. Differences, in any case, are difficult to interpret since most reported studies do not specify the prevalence of iodised salt and supplementation. UIC levels in studies among pregnant women from other developed countries also show great variability, as reviewed by Zimmermann, with median values ranging from less than 33 to 254 mg/l.
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Few large series of pregnant women have reported iodine intake estimates from questionnaires. The Danish National Birth Cohort, using a similar methodology (estimates of iodine from diet plus iodised salt), reported similar levels of iodine intake than those observed in iodised salt consumers from our study. 36 The Norwegian Mother and Child Cohort Study, however, reported a much lower value (median 121 mg/day), but this estimate did not include the contribution of iodine-fortified salt. 37 38 Higher iodine intake from the different sources was associated with higher UIC. Water intake, however, showed the opposite effect underlining the influence of hydration status when assessing UIC. 31 Higher UIC in Latin American than in Spanish women could be explained by some dietary iodine source not accounted for in the FFQ, and also by previous iodine store status or genetic factors. 39 UIC was not associated with gestational age, agreeing with most previous works. 3 One of the main strengths of this study is the possibility of assessing the relative importance of iodine intake from different sources on UIC levels in a large population-based sample of pregnant women. On the other hand, some limitations of the study in measuring iodine intake may relate to dietary assessment method through questionnaires, starting from the measurement error in estimations from a FFQ 40 (choice of portion sizes and frequency of intake) and the limitations from food composition data due to the variability in iodine content of foods according to their origins. 41 In addition, iodised salt use could have been misclassified by some pregnant women not aware of the type of salt they consumed. Furthermore, sources of variability, such as degradation of iodine content, could lead to an imprecise estimation of the iodine amount provided by salt. 42 Last, some iodine sources remain unknown, as is the case of water, whose iodine content depends on the aquifer. 43 On the other hand, UIC is also limited as a proxy of iodine intake since it strongly depends on recent intakes, contrasting with longerterm FFQ estimates. 30 44 45 In addition, UIC from a spot urine sample is conditioned by total daily water intake as the present study has shown. The best alternative would be the use of 24 h urinary iodine, as well as short-term dietary records. 38 46 However, its collection would be complex in a large cohort like this, with the added risk of withdrawal, especially critical in cohort studies. Despite all these potential threats, the multivariate model confirms the independent contribution of the three different sources of iodine intake to UIC levels. Women should be provided with an adequate iodine intake long before they become pregnant to avoid gestational goitrogenesis. 2 43 47 48 Thus, the way proposed by WHO to achieve an adequate iodine nutrition for the whole population, including pregnant women, is universal salt iodisation. 22 The main goal is more than 90% of households using iodised salt.
If we take into account the prevalence of iodised salt consumption in our study, below the WHO recommendation, and the median UIC under the recommended range of 150e249 mg/l, we should conclude the existence of an iodine deficiency problem in these areas. 22 However, several questions still arise. Although there is consensus on the increased needs of iodine during pregnancy, it is also important to point out that the extra needs may to some degree be covered by thyroidal iodine stores if the woman lives in an area with sufficient iodine intake. 43 More studies are necessary to evaluate the correspondence between UIC and iodine intake during pregnancy, especially in iodine-sufficient areas, to validate the current WHO UIC recommended ranges, 48 since this extrapolation may be less valid in this period due to metabolic and excretion changes.
As recommended by WHO, 22 main efforts should be aimed at the implementation of a global programme of iodised salt consumption that provide women with an adequate intake from long before pregnancy, avoiding the risk of an insufficient intake until the first prenatal care visit, when part of the most critical period is over. 39 49 50 Moreover, if supplement intake during pregnancy is implemented in women with a long-standing What is already known on this subject < Iodine is an essential constituent of thyroid hormones. Needs of thyroid hormones are increased during pregnancy, when the fetus is completely dependent on maternal transference for optimal brain development. As a result, new WHO recommendations suggest that reference ranges about iodine intake and urinary iodine concentration in pregnant women should be increased. < Iodine deficiency is already a public health hazard in many European countries. Programmes on education and fortification should be developed to balance iodine intake in vulnerable groups such as pregnant women and to monitor its permanence.
What this paper adds < Uneven implementation of iodine deficiency prevention programmes has led to different iodine status in pregnant women from the three studied areas in Spain. Diet alone is insufficient to grant adequate iodine nutrition during pregnancy, while consumption of high doses of supplements in iodised salt consumers may lead to an excessive iodine intake. < Iodine intake estimates from diet, iodised salt and supplementation were associated with UIC. However, questionnaires led to higher intake estimates than those derived from UIC measured in spot urine samples. More data are necessary to establish precise correspondences between the available instruments to estimate iodine intake during pregnancy. < A global and sustainable programme on iodised salt consumption is required in Spain to provide women with an adequate intake from long before pregnancy, and to avoid the risks of iodine deficiency and excessive intake.
consumption of iodised salt, the possible risks of an excessive iodine intake should be taken into consideration, which may also impair maternal thyroid function.
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